Publikationen 2024

Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohort.
BJU Int 2024; 133(5): 548-554;
Chaloupka M, Pyrgidis N, Ebner B, Volz Y, Pfitzinger PL, Berg E, Enzinger B, Atzler M, Ivanova T, Clevert DA, Buchner A, Stief CG, Apfelbeck M

Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions.
Biomed Pharmacother 2024; 177
Tamalunas A, Wendt A, Springer F, Vigodski V, Trieb M, Eitelberger N, Poth H, Ciotkowska A, Rutz B, Hu S, Schulz H, Ledderose S, Rogenhofer N, Kolben T, Nössner E, Stief CG, Hennenberg M

The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the Bladder.
Cancers (Basel) 2024; 16(8):1536
Tamalunas A, Aydogdu C, Unterrainer LM, Schott M, Rodler S, Ledderose S, Schulz GB, Stief CG, Casuscelli J

Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center.
Cancers (Basel) 2024; 16(12):2246
Rodler S, Aydogdu C, Brinkmann I, Berg E, Kopliku R, Götz M, Ivanova T, Tamalunas A, Schulz GB, Heinemann V, Stief CG, Casuscelli J

Effects of Intraoperative Opioid Use and a Combined Anesthesia Protocol in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder—A Single-Center Experience.
Cancers. 2024; 16(19):3411
Marcon J, Yefsah F, Schulz GB, Weinhold P, Rodler S, Eismann L, Volz Y, Pfitzinger PL, Stief CG, Kowalski C, Siegl D, Buchner A, Pyrgidis N, Jokisch JF

Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
Clin Genitourin Cancer 2024; 22(2): 189-192;
Staehler M, Rodler S, Brinkmann I, Stief CG, Graser A, Götz M, Herlemann A

mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
Clin Hemorheol Microcirc 2024; 86(1-2): 63-70;
Chaloupka M, Pyrgidis N, Ebner B, Pfitzinger P, Volz Y, Berg E, Abrarova B, Atzler M, Ivanova T, Pfitzinger P, Stief CG, Apfelbeck M, Clevert DA

Physician reported toxicities and patient reported quality of life of transperineal ultrasound-guided radiotherapy of prostate cancer.
Clin Trans Rad Onc 2024; 49: 100868;
Ma J, Rogowski P, Trapp C, Manapov F, Xu B, Buchner A, Lu S, Schmidt-Hegemann N, Wang X, Zhou C, Stief C, Belka C, Li M

PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer.
EJNMMI Rep 2024; 8(1)
Sheikh GT, Trapp C, Schmidt-Hegemann NS, Buchner A, Stief CG, Unterrainer M, Kunz WG, Cyran CC, Grawe F, Delker A, Zacherl MJ, Holzgreve A, Unterrainer LM, Brendel M, Belka C, Li M, Rogowski P

Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.
Eur J Nucl Med Mol Imaging 2024;
Trapp C, Aebersold DM, Belka C, Casuscelli J, Emmett L, Eze C, Fanti S, Farolfi A, Fendler W, Grosu AL, Guckenberger M, Hruby G, Kirste S, Koerber SA, Kroeze S, Peeken JC, Rogowski P, Scharl S, Shelan M, Spohn SKB, Strouthos I, Unterrainer L, Vogel M, Wiegel T, Zamboglou C, Schmidt-Hegemann NS

[68Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study.
Eur J Nucl Med Mol Imaging 2024; 51(11): 3461-3464
Eismann L, Ledderose ST, Enzinger B, Berg E, Westhofen T, Rodler S, Schulz GB, Toms J, Holzgreve A, Gildehaus FJ, Brendel M, Cyran CC, Unterrainer M, Stief CG, Bartenstein P, Schlenker B, Unterrainer LM

[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
Eur J Nucl Med Mol Imaging 2024;
Unterrainer LM, Eismann L, Lindner S, Gildehaus FJ, Toms J, Casuscelli J, Holzgreve A, Kunte SC, Cyran CC, Menold P, Karl A, Unterrainer M, Ledderose ST, Stief CG, Bartenstein P, Kretschmer A, Schulz GB

Self-reported exhaustion and a 4-item physical frailty index to predict the incidence of major complications after onco-geriatric surgery.
Eur J Surg Oncol 2024; 50(7);
Scholtz K, Borchers F, Mörgeli R, Krampe H, Schmidt M, Eckardt-Felmberg R, von Dossow V, Sehouli J, Stief CG, Pohrt A, Spies CD, PERATECS Group

Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Eur Radiol 2024; 34(2): 1157-1166;
Grawe F, Blom F, Winkelmann M, Burgard C, Schmid-Tannwald C, Unterrainer LM, Sheikh GT, Pfitzinger PL, Kazmierczak P, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ruebenthaler J, Fabritius MP, Geyer T

Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register.
Eur Urol Focus 2024;
Pyrgidis N, Volz Y, Ebner B, Westhofen T, Staehler M, Chaloupka M, Apfelbeck M, Jokisch F, Bischoff R, Marcon J, Weinhold P, Becker A, Stief C, Schulz GB

Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney.
Eur Urol Oncol 2024;
Tan VS, Correa RJM, Warner A, Ali M, Muacevic A, Ponsky L, Ellis RJ, Lo SS, Onishi H, Swaminath A, Suk Kwon Y, Morgan SC, Cury FL, Teh BS, Mahadevan A, Kaplan ID, Chu W, Hannan R, Staehler M, Zaorsky NG, Louie AV, Siva S

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Eur Urol Oncol 2024; 7(4): 721-734;
Rajwa P, Robesti D, Chaloupka M, Zattoni F, Giesen A, Huebner NA, Krzywon A, Miszczyk M, Moll M, Stando R, Cisero E, Semko S, Checcucci E, Devos G, Apfelbeck M, Gatti C, Marra G, van den Bergh RCN, Goldner G, Rasul S, Ceci F, Dal Moro F, Porpiglia F, Gontero P, Bjartell A, Stief C, Heidenreich A, Joniau S, Briganti A, Shariat SF, Gandaglia G, EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party

Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells.
FASEB J 2024; 38(7)
Liu Y, Huang R, Wang R, Tamalunas A, Waidelich R, Stief CG, Hennenberg M

[Robotic-assisted harvesting of a latissimus dorsi muscle flap: a case report].
Handchir Mikrochir Plast Chir 2024;
Ehrl D, Nuernberger T, Stief C, Karcz K, Giunta RE

Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND study.
Int J Impot Res 2024;
Pyrgidis N, Schulz GB, Chaloupka M, Volz Y, Pfitzinger PL, Berg E, Weinhold P, Jokisch F, Stief CG, Becker AJ, Marcon J

Ligand-Receptor Interactions and Structure-Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors.
Int J Mol Sci 2024; 25(13)
Huang R, Yu Q, Tamalunas A, Stief CG, Hennenberg M

Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data Study.
J Clin Med 2024; 13(12)
Pyrgidis N, Moschini M, Tzelves L, Somani BK, Juliebø-Jones P, Del Giudice F, Mertens LS, Pichler R, Volz Y, Ebner B, Eismann L, Semmler M, Pradere B, Soria F, Stief CG, Schulz GB

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol 2024;
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK, CLEAR Trial Investigators

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
J Clin Oncol 2024; 42(20): 2446-2455;
Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, Zengerling F, Schwab C, Nagy D, Toma M, Kristiansen G, Heers H, Ivanyi P, Niegisch G, Grunewald CM, Darr C, Farid A, Schlack K, Abbas M, Aydogdu C, Casuscelli J, Mokry T, Mayr M, Niedersüß-Beke D, Rausch S, Dietrich D, Saal J, Ellinger J, Ritter M, Alajati A, Kuppe C, Meeks J, Vera Badillo FE, Nakauma-González JA, Boormans J, Junker K, Hartmann A, Grünwald V, Hölzel M, Eckstein M

Perioperative Outcomes of Same-Session Bilateral vs Unilateral Ureteroscopy for Stone Removal: Results from the GRAND Study.
J Endourol 2024; 38(2): 129-135;
Pyrgidis N, Chaloupka M, Ebner B, Stief C, Weinhold P, Marcon J, Schulz GB

Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
JAMA Oncol 2024; 10(6): 755-764;
Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J, TITAN-TCC Study Group

Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey.
JCO Oncol Pract 2024;
Leonard S, Helstrom E, Correa A, Sindhani M, Uzzo N, Jia AY, Kutikov A, Uzzo R, Psutka SP, Calaway A, Klaassen Z, Staehler M, Smaldone M, Wallis CJD, Bukavina L

Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol 2024; 25(5): e193-e204;
Marvaso G, Jereczek-Fossa BA, Zaffaroni M, Vincini MG, Corrao G, Andratschke N, Balagamwala EH, Bedke J, Blanck O, Capitanio U, Correa RJM, De Meerleer G, Franzese C, Gaeta A, Gandini S, Garibaldi C, Gerszten PC, Gillessen S, Grubb WR, Guckenberger M, Hannan R, Jhaveri PM, Josipovic M, Kerkmeijer LGW, Lehrer EJ, Lindskog M, Louie AV, Nguyen QN, Ost P, Palma DA, Procopio G, Rossi M, Staehler M, Tree AC, Tsang YM, Van As N, Zaorsky NG, Zilli T, Pasquier D, Siva S

Hyperspectral imaging for monitoring of free flaps of the oral cavity: A feasibility study.
Lasers Surg Med 2024; 56(2): 165-174;
Felicio-Briegel A, Linek M, Sroka R, Rühm A, Freymüller C, Stocker M, Baumeister P, Reichel C, Volgger V

Influence of vitamins and food on the fluorescence spectrum of human urine.
Lasers Surg Med 2024; 56(5): 485-495;
Chalissery P, Homann C, Stepp H, Eisel M, Aumiller M, Rühm A, Buchner A, Sroka R

Simple Characterization of Cylindrical Diffuser Fibers With a Fluorescent Layer.
Lasers Surg Med 2024; 56(6): 597-605;
Stepp H, Sroka R

[Benign prostatic syndrome - epidemiology, aetiology, diagnostic evaluation].
MMW Fortschr Med 2024; 166(8): 36-39;
Kidess M, Keller P, Tamalunas A, Askari-Motlagh D, Atzler M, Karatas D, Stadelmeier L, Stief CG, Weinhold P

[Macrohaematuria].
MMW Fortschr Med 2024; 166(3): 46-48;
Eismann L, Stief CG, Bischoff R

[Medical treatment of non-neurogenic male LUTS].
MMW Fortschr Med 2024; 166(8): 40-43;
Tamalunas A, Keller P, Götz M, Atzler M, Kidess M, Stadelmeier L, Ebner B, Hennenberg M, Stief CG, Weinhold P

Update gutartige Prostatavergrößerung. Editorial.
MMW Fortschr Med 2024; 166(8);
Stief CG

Assessing Stress Induced by Fluid Shifts and Reduced Cerebral Clearance during Robotic-Assisted Laparoscopic Radical Prostatectomy under Trendelenburg Positioning (UroTreND Study).
Methods Protoc 2024; 7(2)
Peschke T, Feuerecker M, Siegl D, Schicktanz N, Stief C, Zu Eulenburg P, Choukér A, Buchheim JI

Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Naunyn Schmiedebergs Arch Pharmacol 2024; 397(2): 1219-1231;
Hu S, Trieb M, Huang R, Tamalunas A, Keller P, Götz M, Waidelich R, Stief CG, Hennenberg M

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.
Nutrients 2024; 16(11)
Ebrahimi H, Battle D, Salgia NJ, Zengin ZB, Dizman N, Meza L, Bergerot CD, Barragan-Carrillo R, Hsu J, Castro D, Mercier B, Chawla N, Li X, Tripathi A, Liu ST, Chehrazi-Raffle A, Vaishampayan U, Staehler MD, Pal SK

Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications.
Pharmacol Rep 2024;
Hu S, Müderrisoglu AE, Ciotkowska A, Kale O, Keller P, Schott M, Tamalunas A, Waidelich R, Stief CG, Hennenberg M

Investigations on correlations between changes of optical tissue properties and NMR relaxation times.

Photodiagnosis Photodyn Ther 2024; 45()
Aumiller M, Arazar A, Sroka R, Dietrich O, Rühm A

Accuracy of robotic radiosurgery in renal cell carcinoma.
Phys Med 2024; 122
Hofmann T, Kohlhase N, Eftimova D, Eder MM, Staehler M, Ruge MI, Muacevic A, Fürweger C

Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
Prostate 2024; 84(2): 131-147;
Wang L, Lyu C, Stadlbauer B, Buchner A, Nößner E, Pohla H

An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy.

Prostate Cancer Prostatic Dis 2024;
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M, Young Academic Urologists working group on Prostate Cancer of the European Association of Urology

Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy.
Spectrochim Acta A Mol Biomol Spectrosc 2024; 304()
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A

Investigation on the influence of the skin tone on hyperspectral imaging for free flap surgery.
Sci Rep 2024;14(1):13979;
Pachyn E, Aumiller M, Freymüller C, Linek M, Volgger V, Buchner A, Rühm A, Sroka R

Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?

Transfusion 2024; 64(1): 29-38;
Ebner B, Fleckenstein F, Volz Y, Eismann L, Hermans J, Buchner A, Enzinger B, Weinhold P, Wichmann C, Stief CG, Humpe A, Pyrgidis N, Schulz GB

The prognostic value of perioperative platelet and leukocyte values in patients undergoing radical cystectomy: a prospective long-term cohort study.
Urol Int 2024;
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F

Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?

Urol Int 2024; 108(1): 42-48;
Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermanns J, Pyrgidis N, Stief C, Schulz GB

Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma.

Urol Oncol 2024; 42(2): 32.e9-32.e16;
Reese SW, Eismann L, White C, Villada JA, Khaleel S, Ostrovnaya I, Vazquez-Rivera K, Carlo MI, Feldman D, Lee CH, Motzer R, Voss MH, Kotecha RR, Matulewicz RS, Goh A, Coleman J, Russo P, Hakimi AA

Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma with Synchronous and Metachronous Nodal Disease.
Urol Pract 2024;
Eismann L, Zucker M, Dawidek MT, Reese SW, Calderon LP, Aulitzky A, Stief CG, Coleman JA, Kotecha RR, Carlo M, Chen Y, Reznik E, Russo P, Hakimi AA

[Perineal prostate biopsy].
Urologie 2024; 63(9): 934-942;
Pfitzinger PL, Askari DA, Ivanova T, Hoffmann M, Blajan I, Atzler M, Stadelmeier LF, Apfelbeck M, Chaloupka M, Kazmierczak P, Stief C, Enzinger B

[Treatment of localized renal cell carcinoma].
Urologie 2024; 63(2): 176-183;
Brinkmann I, Stief CG, Marcon J

Re: letter to the editor for the article "Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy".
World J Urol 2024; 42(1)
Rodler S, Stief C, Westhofen T

The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data.
World J Urol 2024; 42(1)
Pyrgidis N, Volz Y, Ebner B, Kazmierczak PM, Enzinger B, Hermans J, Buchner A, Stief C, Schulz GB

The impact of health care on outcomes of suspected testicular torsion: results from the GRAND study.
World J Urol 2024; 42(1)
Pyrgidis N, Apfelbeck M, Stredele R, Rodler S, Kidess M, Volz Y, Weinhold P, Stief CG, Marcon J, Schulz GB, Chaloupka M

The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
World J Urol 2024; 42(1)
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F

The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal study.
World J Urol 2024; 42(1)
Westhofen T, Frank K, Buchner A, Becker A, Eismann L, Rodler S, Aydogdu C, Berg E, Jokisch F, Kazmierczak PM, Stief CG, Kretschmer A